NewsRoom Articles - Page 290 of 600

ThursdayFeb 04, 2021 12:10 pm

CBD Market Steadiness Buoys HempFusion Wellness Inc. (TSX: CBD.U) (OTC: CBDHF) Hopes as TSX Launch Completed

Health and wellness company HempFusion Wellness, Inc. launched its IPO Jan. 6 with the ticker CBD.U, and also trades in the US under the symbol CBDHF The company distributes its brands HempFusion, Probulin Probiotics, Biome Research and HF Labs to 4,000 retailers in every state as well as select international locales, and is strategically planning for expansion Despite the economic battering some industries have experienced as a result of the global pandemic, hemp and CBD continue to see consumer use trends holding stable with forecasts for new market growth in coming years HempFusion is focused on regulatory compliance with industry…

ThursdayFeb 04, 2021 4:20 am

420 with CNW — Schumer Says Cannabis Legalization Will Be Senate Priority

Late last year, the U.S. House of Representatives passed a historic bill that would decriminalize marijuana at the federal level and expunge nonviolent, cannabis-related convictions. Although the legislation was applauded by drug reform activists, it was almost certainly doomed in the then Republican-controlled Senate, with GOP leaders dubbing cannabis legalization a superficial distraction from COVID relief. However, now that the Democrats control both the Senate and the House, cannabis legalization may be a reality. In a recent interview with former NBA player Al Harrington who owns cannabis company Viola Brands, Senate Majority Leader Chuck Schumer discussed his support for ending…

WednesdayFeb 03, 2021 4:20 pm

420 with CNW — France to Dispense Free Medical Marijuana to Patients in New Pilot Project

Despite the fact that France’s program to supply medical marijuana to patients was postponed because of the coronavirus pandemic, the country recently released a list of firms that had won bids to supply this free cannabis. The program is scheduled to run for approximately six months, and the marijuana products to be distributed would be in form of oil and dry flower. The companies include Emmac Life Sciences, Panaxia, Tilray, Aurora Cannabis, Little Green Pharma and Althea. While the companies that were selected are not based in France, they will be working with companies that are based in France. This…

WednesdayFeb 03, 2021 3:38 pm

Grapefruit USA Inc. (GPFT) Is ‘One to Watch’

Grapefruit USA Inc. holds licensing for manufacturing and distribution in California, issued in 2018; the company is positioned as a premier distributor and manufacturer in the state, with a focus on procuring, manufacturing and distributing the highest-quality materials With cannabis legalization gaining momentum worldwide, Grapefruit is currently uniquely situated to disrupt the market through its novel and proprietary products and services The global cannabis market is expected to grow to $97.35 billion by 2026, expanding at a CAGR of 32.92% The company provides a wealth of cannabis flower and cannabis products to licensed businesses, along with various services including distribution,…

WednesdayFeb 03, 2021 3:00 pm

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Updates Investors Following Completion of Special Warrants Private Placement

Pure Extracts recently updated investors on successful completion of second tranche of its special warrants private placement In aggregate, Company will raise gross proceeds of $8.5 million through both tranches of private placement Pure Extracts will employ net proceeds from private placement towards capacity expansion for Company’s extraction business, and for general working capital purposes Company previously revealed that it was conducting study looking into formulation, manufacturing of psilocybin-based active treatments Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company focused on the cannabis, hemp, and functional mushroom sectors, has recently updated investors following the successful…

WednesdayFeb 03, 2021 2:24 pm

PacRoots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) Set to Thrive as Peers Face Pain of Excess Supply

PacRoots Cannabis recently updated investors following its first successful hemp harvest, which resulted in 105,000 lbs. of biomass of higher-than-expected quality Canadian cannabis market is currently awash in oversupply, with some estimates placing inventory stockpile at close to 3 years’ worth of demand Industry participants have pointed at low-quality grades as prime cause for the oversupply PacRoots has taken strides to improve quality of its plants, most notably through collaboration with Phenome One Corp PacRoots processes, sells entirety of recent harvest to the Speakeasy Cannabis Club PacRoots Cannabis (CSE: PACR) (OTCQB: PACRF), an up-and-coming cannabis company based out of Canada,…

WednesdayFeb 03, 2021 1:55 pm

RYAH Group Inc. Partners with THC Lab to Launch Dose-Measuring Inhaler and Data Analytics Platform in Italy, Netherlands

Agreement between RYAH, THC Lab outlines parameters for launch of RYAH’s IoT dose-measuring Smart-Inhaler Aim of agreement is to reach hundreds of pharmacies, establish RYAH as the market standard for vaporizing The two companies also planning to work together on controlled research, bioavailability testing projects RYAH Group, a leading digital health care analytics and technology company, has entered into a research-and-distribution arrangement THC Lab, which specializes in providing products and services to compounding pharmacies in Italy and other European countries in the specific field of medical cannabis (https://cnw.fm/9S8To). The agreement outlines the parameters for the launch of RYAH’s IoT dose-measuring…

WednesdayFeb 03, 2021 4:20 am

420 with CNW — Locations with Cannabis Dispensaries Recorded Fewer Opioid Fatalities, New Research Says

A new study has shown that a significant decline in deaths related to opioids is linked to improved access to cannabis dispensaries. The study, which was reported in the “British Medical Association” journal, concluded that higher counts of recreational and medical dispensary stores were connected with decreased opioid-related mortality rates, particularly deaths linked to synthetic opioids such as fentanyl. The study adds that the discovery holds for both recreational and medical dispensaries. The researchers examined the prevalence of marijuana dispensaries and opioid death rates in 23 states between the years of 2014 and 2018. The researchers discovered that, in general,…

TuesdayFeb 02, 2021 4:20 pm

420 with CNW — Could Canna-Tourism Trigger Economic Recovery?

Just as the global economy was finally recovering from the 2007–2008 financial crisis, the coronavirus pandemic struck, effectively plunging the world into the worst recession since World War 2. International travel came to a near-total standstill as countries tried to prevent the virus from entering their borders, disrupting global supply chains. The resultant lockdown and self-distancing orders were devastating for most industries; one of the hardest hit was the hospitality sector, which shouldered millions of lost jobs. The cannabis industry fared relatively well, on the other hand, with cannabis companies reporting month-over-month sales records even as the pandemic ravaged the…

TuesdayFeb 02, 2021 3:36 pm

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Is ‘One to Watch’

XPhyto Therapeutics Corp. is a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment opportunities The company has research and development operations in North America and Europe and an operational focus in Germany XPhyto’s operations are concentrated into three core divisions: infectious disease diagnostics, clinical development of transdermal and sublingual drug formulations, and psychedelic medicine The company’s lead diagnostic product is an accurate, rapid and highly portable PCR diagnostic test system being evaluated in Europe for the detection of COVID-19 XPhyto’s German subsidiary, Vektor Pharma TF GmbH, is advancing four therapeutic programs targeting neurological indications;…